Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
34,467,544
-
Shares change
-
+2,073,666
-
Total reported value, excl. options
-
$1,811,286,824
-
Value change
-
+$117,879,421
-
Put/Call ratio
-
121%
-
Number of buys
-
94
-
Number of sells
-
-76
-
Price
-
$52.55
Significant Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q2 2017
206 filings reported holding AERI - AERIE PHARMACEUTICALS INC - COM as of Q2 2017.
AERIE PHARMACEUTICALS INC - COM (AERI) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,467,544 shares
.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3,450,000 shares), WELLINGTON MANAGEMENT GROUP LLP (3,318,106 shares), BlackRock Inc. (2,602,824 shares), VANGUARD GROUP INC (2,158,825 shares), Foresite Capital Management III, LLC (1,950,477 shares), JENNISON ASSOCIATES LLC (1,885,075 shares), ORBIMED ADVISORS LLC (1,831,647 shares), Partner Fund Management, L.P. (1,748,040 shares), Foresite Capital Management II, LLC (1,672,714 shares), and DEERFIELD MANAGEMENT CO (961,147 shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.